POSTER SESSION VI
Wednesday, March 26, 2003   1:00 - 4:00 PM
Exhibit Hall A - C
HEMATOPATHOLOGY
148
DRAQ5-Based Cell Cycle Analysis of Cell Subpopulations Discriminated by Surface Antigens and Light Scatter in Hematopoietic Tissues
(1189)
C Yuan, V Douglas, G Luchetta, K Ahrens, R Braylan, L Yang
University of Florida College of Medicine, Gainesville, FL
149
Plasma Cell Myeloma Involving Cerebrospinal Fluid: 10-year Experience in a Myeloma Center
(1111)
S Mathew, L Joseph, A Fassas, AJ Hough, M Gokden
University of Arkansas for Medical Sciences, Little Rock, AR
150
Syndecan-1 (CD138) Expression in Normal Tissues and Non-Hematolymphoid Neoplasms Using Tissue Microarrays
(1087)
N Kambham, T Longacre, Y Natkunam
Stanford University, Stanford, CA
151
CD138 (Syndecan-1), a Plasma Cell Marker: Immunohistochemical Profile in Hematopoietic and Non-Hematopoietic Neoplasma
(1125)
FP O'Connell, GS Pinkus, JL Pinkus
Brigham and Women's Hospital and Harvard Medical School, Boston, MA
152
CD138 (Syndecan-1) in Lymphoid Neoplasms: A Paraffin Immunohistochemical (IHC) Study with Flow Cytometry (FC) Correlation
(1047)
G Deeb, R Kansal, CC Stewart, M Barcos
State University of New York at Buffalo, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY
153
Use of CD138 and CD56 by Immunohistochemistry for Classifying Plasma Cell Dyscrasias
(1124)
L Novoa-Takara, D Buchbinder, B Kampalath, C-C Chang
Medical College of Wisconsin, Milwaukee, WI
154
Early Assessment of Engraftment after Stem Cell Transplant (SCT) for Multiple Myeloma (MM)
(1150)
MR Sheikholeslami, MH Cttler-Fox
Univ. of Arkansas for Medical Sciences, Little Rock, AR
155
Plasma Cell Immunophenotype of Paired Peripheral Blood and Bone Marrow Samples in 11 Myeloma Patients
(1191)
F Zhang, OB Rebecca, Z Maurizio, P Lin
University of Arkansas for Medical Sciences, Little Rock, AR; M.D. Anderson Cancer Center, Houston, TX
156
Different Mechanisms of Cyclin D1 and Myeov Overexpression in Multiple Myeloma Revealed by Quantitative Analysis of mRNA Levels
(1156)
K Specht, E Haralambieva, M Kremer, S Mandl-Weber, K Bink, H Hofler, E Schuuring, PM Kluin, F Fend, L Quintanilla-Martinez
Technical University Munich, Munich, Germany; Academic Hospital Groningen, Groningen, Netherlands; GSF-National Research Center for Environment and Health, Neuherberg, Germany
157
Depsipeptide Induces Apoptosis in Multiple Myeloma Cell Lines
(1092)
SB Khan, T Maududi, S Alkan
Loyola University Medical Center, Maywood, IL
158
Quantitation of Clonotypic B-Cells in Multiple Myeloma (MM) Patients Prior to Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Correlates with Outcome of MM Patients after APBSCT
(1049)
R Dimitrov, L Novoa-Takara, DH Vesole, D Buchbinder, C-C Chang
Medical College of Wisconsin, Milwaukee, WI
159
Flowcytometry Data as a Criteria for Diagnosis of Multiple Myeloma
(1097)
S Konoplev, V Sundararajan, C Alvares, S Sylvest, P Hurtubise
University of Cincinnati, Cincinnati, OH
160
Evaluation of Immunoglobulin (Ig) mRNA and the Nuclear Factors Oct2 and BOB.1 in Nonsecretory Multiple Myeloma (NSMM)
(1032)
RC Beck, G Srkalovic, M Hussein, ED Hsi
The Cleveland Clinic Foundation, Cleveland, OH
161
Bone Marrow Biopsy Pathology of Poems Syndrome
(1114)
DM Menke, HP Horny, A Dispenzieri
Mayo Clinic, Jacksonville, FL; University of Lubeck, Lubeck, Germany; Mayo Clinic, Rochester, MN
162
Correlation between Size of IgM M-Spike and Diagnosis in Chronic Lymphoproliferative Disorders
(1140)
ED Remstein, WR Macon, RA Kyle, JM Hodnefield, PJ Kurtin
Mayo Clinic, Rochester, MN
163
Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) in Bone Marrow: Pax-5 Immunostain Highlights a Vascular-Centered Tumor Growth with Variations in Cellular Composition and Architecture in Lymphoplasmacytoid, Lymphoplasmacytic and Polymorphous Subtypes
(1173)
A Wahed, LJ Medeiros, A Mansoor, CE Bueso-Ramos
MD Anderson Cancer Center, Houston, TX
164
All Surface Light Chain Negative Mature B Cell Proliferations Show Cytoplasmic Light Chain Restriction by Flow Cytometry
(1163)
M Taskin, J Opera, IR Grossman, AY Gritsman
The Valley Hospital, Ridgewood, NJ; University of Medicine and Dentistry of NJ
165
Flow Cytometric Detection of Biclonal B-Cell Lymphoma
(1068)
W Gorczyca, Z Liu, D Wu, H Dong, P Cohen, J Weisberger
IMPATH, Inc., New York City, NY
166
CD38 and CD138 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
(1088)
B Kampalath, L Novoa-Takara, N Rao, VB Shidham, C-C Chang
Medical College of Wisconsin, Milwaukee, WI
167
Treatment of Human Chronic Lymphocytic Leukemia Cells with a Proteasome Inhibitor (PS341) Promotes Apoptosis
(1090)
TW Kelley, S Alkan, ED Hsi
Cleveland Clinic Foundation, Cleveland, OH; Loyola Univ Medical Center, Maywood, IL
168
Clinical Significance of Incidentally Identified Minute Clonal B-Lymphocyte Populations in Peripheral Blood and Bone Marrow
(1040)
W Chen, SL Asplund, RW McKenna, SH Kroft
University of Texas Southwestern Medical Center, Dallas, TX
169
Comparision of Methods for Diagnosis of Follicular Lymphoma (FL) in Bone Marrow (BM)
(1072)
S Hao, P Lin, LJ Medeiros
University of Texas MD Anderson Cancer Center, Houston, TX
170
Characterization of Bone Marrow Lymphoid Aggregates in Follicular Lymphoma Treated with [131I] Anti-B1 Antibody
(1146)
D Selby, R Padmore, M Tuck, C Ross, B Schnitzer, W Finn, R Valdez, T Singleton, M Kaminski
University of Michigan, Ann Arbor, MI
171
The Clinical Significance of the t(11;14) (q13;q32) Translocation Detected by FISH in the Bone Marrow of Patients with Mantle Cell Lymphoma in Remission
(1038)
S-N Cao, NP Caraway, M Albitar, IB Jilani, J Gu, T Zaidi, JE Romaguera, RL Katz
The University of Texas M. D. Anderson Cancer Center, Houston, TX
172
Activation-Induced Cytidine Deaminase (AICD) Expression Distinguishes Subtypes of Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
(1022)
LV Abruzzo, H McCarthy, WG Wierda, LL Barron, CC Cromwell, D Jones, R Lai, MJ Keating, LJ Medeiros
UT M.D. Anderson Cancer Center, Houston, TX
173
CD10-Positive Hairy Cell Leukemia
(1085)
TM Jasionowski, L Hartung, JH Greenwood, J Hussong, SL Perkins, DW Bahler
University of Utah, Salt Lake City, UT; Sunrise Humana Hospital, Las Vegas, NV
174
Bone Marrow Involvement in AIDS-Related Lymphoma
(1168)
TE Troe, O Ozer, MJ Fidler, A Okonkwo, D Variakojis
Mcgaw Medical Center of Northwestern Univiversity, Chicago, IL
175
CD8 T Cell Lymphocytosis and Stem Cell Depletion in HIV-1 Positive Marrow Biopsies: Correlation with Anemia and Thrombocytopenia
(1176)
L Wang, SD Hudnall
University of Texas Medical Branch, Galveston, TX
176
Large Granular Lymphocytic Leukemia of the Gamma/Delta ((*) T-Cell Type
(1110)
Z Liu, W Gorczyca, HY Dong, S Tugulea, X Li, J Weisberger
IMPATH Inc., New York, NY
177
Bone Marrow Disease in Nodular Lymphocyte Predominant Hodgkin Disease (NLPHD)
(1093)
JD Khoury, D Jones, MA Yared, JT Manning, LV Abruzzo, LJ Medeiros
M.D. Anderson Cancer Center, Houston, TX